medic
countermeasur
prevent
treat
smallpox
need
due
potenti
use
poxvirus
biolog
weapon
safeti
concern
current
avail
smallpox
vaccin
indic
need
research
altern
poxviru
vaccin
strategi
molecular
vaccin
involv
use
protein
andor
gene
recombin
antibodi
among
strategi
current
investig
poxviru
protein
encod
open
read
frame
target
neutral
antibodi
success
use
compon
protein
subunit
dna
vaccin
monoclon
antibodi
eg
mous
monoclon
antibodi
potent
neutral
activ
bind
conformationspecif
manner
suggest
proper
fold
protein
use
molecular
vaccin
affect
product
neutral
antibodi
protect
cocrystal
fab
fragment
protein
crystal
structur
complex
reveal
basi
conformationspecif
bind
recognit
discontinu
epitop
contain
two
loop
held
togeth
disulfid
bond
structur
import
conform
epitop
contribut
develop
molecular
poxviru
vaccin
also
provid
novel
target
antipoxviru
drug
addit
sequenc
structur
contribut
develop
immunotherapeut
result
potenti
bioterror
threat
smallpox
caus
variola
viru
renew
interest
poxviru
vaccin
protect
immun
harrison
et
al
current
vaccin
smallpox
requir
inocul
relat
live
vaccinia
viru
vacv
infect
associ
live
viru
vaccin
lead
complic
correspond
author
mail
address
parklawn
drive
rockvil
maryland
usa
phone
fax
email
dgarboczi
niaidnihgov
two
author
contribut
equal
work
present
address
merck
co
inc
sumneytown
pike
west
point
pa
healthi
individu
immunedefici
individu
pregnant
women
special
risk
henderson
et
al
belongia
naleway
one
current
approach
improv
vaccin
strategi
use
viral
strain
attenu
coulibali
et
al
kidokoro
et
al
altern
use
viral
protein
subunit
andor
gene
molecular
vaccin
approach
develop
molecular
vaccin
requir
identif
poxviru
immunogen
elicit
immun
respons
contribut
protect
galmich
et
al
hooper
et
al
fogg
et
al
davi
et
al
sakhatskyy
et
al
sever
protect
immunogen
identifi
includ
poxviru
protein
encod
open
read
frame
dna
vaccin
protein
subunit
vaccin
elicit
neutral
antibodi
mice
nonhuman
primat
contribut
protect
lethal
diseas
model
fogg
et
al
hooper
et
al
heraud
et
al
xiao
et
al
myristoyl
transmembran
protein
found
surfac
matur
virion
mv
form
poxvirus
ravanello
et
al
conserv
orthopoxvirus
sequenc
almost
ident
among
vacv
variola
viru
monkeypox
viru
delet
gene
block
morphogenesi
prevent
format
infecti
viru
ravanello
hrubi
howev
may
also
play
role
direct
indirect
viral
entri
cell
monoclon
antibodi
eg
mous
monoclon
antibodi
bind
surfac
virion
effici
neutral
infect
wolff
et
al
ichihashi
oie
hooper
et
al
antibodi
neutral
infect
virion
attach
ichihashi
et
al
wolff
et
al
howev
recent
report
indic
protein
compon
viral
fusion
complex
townsley
et
al
moss
contain
three
disulfid
bond
form
virusencod
redox
pathway
senkevich
et
al
two
three
intramolecular
disulphid
bond
essenti
product
infecti
viral
particl
blouch
et
al
bond
reduc
neutral
antibodi
recogn
wolff
et
al
ichihashi
oie
hooper
jw
schmaljohn
al
unpublish
data
attract
candid
potenti
subunit
vaccin
andor
immunotherapeut
import
understand
natur
epitop
play
crucial
role
antibodymedi
protect
immun
report
investig
natur
interact
mechan
potent
neutral
antibodi
prevent
infect
cocryst
structur
fab
fragment
bound
protein
reveal
basi
conformationspecif
bind
recognit
discontinu
epitop
contain
two
loop
held
togeth
disulfid
bond
perform
cocrystal
studi
involv
recombin
test
differenti
capac
bind
vacv
recombin
purifi
e
coli
purifi
evalu
bind
elisa
plate
coat
purifi
vacv
fig
bound
purifi
viral
antigen
concentr
test
contrast
bound
purifi
virion
fab
concentr
high
observ
similar
elisa
result
use
recombin
purifi
e
coli
antigen
fig
interestingli
purifi
vacv
recombin
treat
ultraviolet
uv
light
reactiv
lost
fig
thu
bound
intact
virion
recombin
protein
albeit
lower
reactiv
bival
form
antibodi
epitop
recogn
antibodi
could
disrupt
expos
uv
light
investig
abil
fragment
neutral
vacv
infect
plaqu
reductionneutr
test
prnt
fig
expect
effici
neutral
vacv
plaqu
format
previous
describ
wolff
et
al
fragment
also
abl
neutral
vacv
plaqu
format
level
similar
intact
immunoglobulin
even
lowest
concentr
test
yield
neutral
contrast
requir
greater
concentr
protein
give
similar
level
neutral
highest
concentr
use
fab
fragment
elicit
reduct
plaqu
number
find
indic
bival
play
role
capac
effici
neutral
vacv
determin
bival
bind
fab
could
increas
neutral
activ
incub
fragment
vacv
ad
antifab
antibodi
assay
neutral
prnt
shown
fig
incub
antifab
antibodi
restor
neutral
activ
find
confirm
bival
inde
play
key
role
abil
neutral
role
bival
enhanc
neutral
could
due
intraandor
interparticl
aggreg
crosslink
investig
pfu
vacv
adsorb
onto
cell
monolay
sinc
pfu
vacv
use
reason
viral
particl
close
enough
permit
interparticl
interact
therefor
allow
us
determin
much
neutral
due
intraparticl
bind
follow
adsorpt
unbound
viru
remov
bound
particl
incub
vari
concentr
either
subsequ
antifab
antibodi
ad
monolay
plaqu
format
analyz
four
day
postinfect
predict
effici
neutral
vacv
plaqu
format
ad
postadsorpt
fig
alon
neutral
viru
poorli
even
highest
concentr
test
viru
inhibit
crosslink
fragment
bound
adsorb
viru
led
mark
increas
viru
neutral
albeit
less
effici
neutral
effect
plu
antifab
antibodi
rapidli
lost
concentr
fab
fragment
reduc
possibl
due
ineffici
bind
crosslink
capabl
neutral
vacv
suggest
signific
portion
bival
neutral
capabl
intraparticl
bind
understand
basi
conform
specif
recognit
structur
complex
determin
xray
crystallographi
tabl
four
copi
complex
present
crystal
asymmetr
unit
bound
surfac
form
four
long
loop
side
molecul
opposit
amino
carboxyl
termini
presum
away
viral
membran
four
loop
connect
helic
helic
bundl
strand
beta
sheet
fig
heavi
chain
compris
recognit
site
fig
total
surfac
area
buri
interfac
heavi
chain
contrast
buri
surfac
area
light
chain
interact
typic
rang
total
surfac
area
buri
interfac
antigen
chain
antibodi
davi
et
al
anoth
measur
qualit
describ
strength
interact
analysi
interact
surfac
given
shape
complementar
statist
sc
perfect
fit
yield
score
lawrenc
colman
heavi
chain
interfac
gave
sc
within
rang
antibodi
antigen
complex
light
chain
interfac
yield
score
indic
poor
complementar
analysi
molecular
interact
also
confirm
light
chain
significantli
contribut
bind
structur
interact
light
chain
within
distanc
contrast
hydrogen
bond
tabl
form
antibodi
residu
loop
loop
held
togeth
disulfid
bond
loop
loop
fig
also
addit
van
der
waal
interact
heavi
chain
loop
tabl
loop
residu
mediat
interact
map
sequenc
fig
previou
studi
report
isol
mutant
vacv
escap
neutral
mous
mab
ichihashi
oie
escap
mutat
gene
result
chang
residu
asp
asn
bind
similar
epitop
want
determin
chang
asp
asn
would
disrupt
bind
cell
transfect
either
plasmid
contain
mutat
plasmid
tissu
plasminogen
activ
tpa
secret
signal
sequenc
insert
upstream
infram
open
read
frame
tpa
permit
process
endoplasm
reticulum
take
advantag
endogen
cellular
disulfid
bond
format
machineri
fold
properli
transmembran
region
remov
molecul
target
plasma
membran
could
detect
antibodi
hooper
et
al
h
posttransfect
abil
antibodi
bind
surfaceexpress
examin
flow
cytometri
fig
indic
shift
fluoresc
intens
interact
mutant
contrast
second
mab
potent
neutral
activ
effici
interact
molecul
neither
interact
cell
transfect
empti
pwrg
vector
compet
bind
vacv
measur
competit
elisa
hooper
jw
schmaljohn
al
unpublish
observ
control
use
antibodi
poxviru
protein
interact
cell
fig
observ
indic
mutat
asn
disrupt
interact
potent
neutral
monoclon
antibodi
even
bound
region
measur
competit
elisa
structur
involv
hydrogen
bond
heavi
chain
base
distanc
atom
capabl
form
hydrogen
bond
tabl
atom
form
hydrogen
bond
heavi
chain
form
hydrogen
bond
atom
heavi
chain
fig
top
chang
asn
hydrogen
bond
could
still
occur
fig
bottom
hydrogen
bond
form
could
replac
similar
hydrogen
bond
altern
rotam
conform
heavi
chain
hydrogen
bond
made
heavi
chain
carbonyl
oxygen
still
form
altern
rotam
fig
bottom
thu
base
structur
complex
provid
explan
bind
mutant
antibodi
may
accommod
hydrogen
bond
escap
mutant
studi
character
bind
potent
neutral
antibodi
recogn
surfac
poxviru
virion
cocryst
structur
reveal
interact
loop
held
togeth
disulfid
bond
conform
loop
stabil
disulfid
bond
provid
explan
molecular
level
previou
report
epitop
disrupt
disulfid
bond
reduct
panel
six
antibodi
recent
character
aldazcarrol
et
al
peptid
map
block
assay
demonstr
mab
bound
two
differ
antigen
site
two
antibodi
bound
conform
epitop
nonneutr
four
antibodi
recogn
linear
pseudolinear
epitop
includ
residu
neutral
aldazcarrol
et
al
block
experi
none
six
mab
bound
conform
epitop
recogn
neutral
antibodi
compet
bind
measur
biacor
aldazcarrol
et
al
bind
site
competit
elisa
cocryst
structur
reveal
overlap
linear
neutral
epitop
includ
residu
conform
epitop
recogn
two
residu
loop
loop
color
purpl
fig
make
van
der
waal
contact
tabl
also
contain
within
linear
epitop
map
antibodi
gener
aldazcarrol
et
al
howev
possibl
contribut
significantli
bind
would
allow
antibodi
bind
simultan
structur
previous
identifi
linear
epitop
suggest
surfac
made
loop
end
access
antibodi
bind
antibodi
region
interfer
event
involv
entri
none
six
mab
character
aldazcarrol
et
al
bind
epitop
recogn
highli
potent
neutral
six
antibodi
gener
immun
mice
ectodomain
produc
baculoviru
express
system
gener
vaccin
infecti
viru
baculovirusexpress
protein
target
endoplasm
reticulum
secret
addit
melittin
signal
peptid
appear
fold
correctli
measur
bind
presenc
three
disulfid
bond
glycosyl
howev
present
baculovirusproduc
protein
unlik
produc
vacvinfect
cell
transloc
cellular
compart
possess
glycosyl
machineri
asn
residu
possibl
nlink
site
shown
glycosyl
aldazcarrol
et
al
glycan
could
alter
immunogen
epitop
make
van
der
waal
contact
tabl
found
correct
conform
epitop
disrupt
uv
light
exposur
vacvinfect
cell
lysat
purifi
protein
uv
light
ablat
bind
fig
data
shown
uv
radiat
like
disrupt
critic
disulfid
bond
requir
gener
highaffin
neutral
epitop
wellknown
uv
light
break
disulfid
bond
especi
photoexcit
aromat
residu
nevespetersen
et
al
vanhooren
et
al
past
uvkil
poxviru
vaccin
test
capac
protect
turner
et
al
retrospect
data
indic
uvinactiv
poxviru
antigen
lack
import
epitop
data
emphas
import
vaccin
intact
correctli
fold
process
protein
provid
discontinu
epitop
form
loop
crosslink
exhibit
exceedingli
potent
neutral
activ
even
ad
viru
adsorpt
cell
monolay
addit
passiv
transfer
experi
mice
indic
mab
elicit
protect
immun
hooper
et
al
lustig
et
al
mechan
neutral
viru
remain
unknown
identifi
precis
region
poxviru
bind
demonstr
bival
bind
enhanc
neutral
activ
antibodi
abil
high
fab
concentr
neutral
viru
suggest
effect
absolut
requir
crosslink
surfac
virion
reduc
interact
intact
vacv
fig
purifi
fig
suggest
poor
neutral
capac
larg
due
avid
reduc
capac
fab
neutral
vacv
report
schmaljohn
et
al
find
similar
report
mab
interact
discontinu
epitop
present
spike
protein
murin
hepat
viru
mhv
lamarr
talbot
studi
bival
significantli
enhanc
neutral
mhv
vitro
vivo
howev
fab
fragment
could
also
neutral
viru
much
lesser
extent
author
conclud
bival
might
enhanc
neutral
steric
hindranc
caus
conform
chang
viral
protein
due
increas
avid
possibl
function
steric
hinder
interact
viral
cellular
molecul
block
conform
chang
virion
requir
entri
studi
requir
identifi
critic
step
infect
process
block
mab
bind
epitop
postattach
step
could
target
mab
includ
trigger
hostcel
signal
pathway
involv
particl
uptak
activ
function
viral
fusion
complex
uncoat
event
requir
deliv
activ
viral
replic
machineri
cytoplasm
complex
structur
provid
detail
molecular
interact
made
heavi
light
chain
sequenc
specif
interact
residu
thu
map
human
develop
therapeut
appropri
human
antibodi
scaffold
may
found
compar
root
mean
squar
deviat
rmsd
known
human
antibodi
structur
could
minim
posit
chang
interact
loop
engin
like
human
immunoglobulin
map
interact
specificitydetermin
residu
also
use
minim
human
antimurin
antibodi
respons
padlan
et
al
kashmiri
et
al
knowledg
molecular
interact
mutat
made
enhanc
bind
molecular
model
may
determin
mutat
would
strengthen
interact
affin
also
improv
experiment
molecular
techniqu
phage
display
wildtyp
light
chain
contribut
significantli
bind
may
possibl
identifi
light
chain
mutat
increas
affin
although
epitop
overlap
differ
bind
mutant
thu
combin
mab
would
like
neutral
antibodi
escap
mutant
aris
crystal
use
determin
structur
alon
two
molecul
pack
togeth
asymmetr
unit
su
et
al
other
observ
monomer
solut
aldazcarrol
et
al
pack
observ
independ
deriv
complex
crystal
studi
two
set
pair
pack
manner
crystal
alon
one
pair
molecul
rmsd
pair
exhibit
rmsd
calcul
use
distanc
dimer
physiolog
relev
complex
structur
indic
antibodi
molecul
could
bind
two
molecul
two
fab
bound
pair
molecul
orient
opposit
direct
work
requir
determin
exact
orient
surfac
virion
neutral
antibodi
block
bind
aldazcarrol
et
al
suggest
interest
possibl
bispecif
antibodi
consist
anoth
specif
block
may
togeth
bind
potenti
exhibit
greater
neutral
activ
futur
work
seek
human
antibodi
either
context
monospecif
bispecif
construct
molecul
use
conjunct
human
antibodi
target
envelop
particl
human
chimpanze
antibodi
chen
et
al
may
serv
replac
vaccinia
immun
globulin
use
treat
sequela
aris
individu
vaccin
liveviru
altern
cocktail
might
function
standalon
antipoxviru
therapeut
lastli
base
crystal
structur
complex
identifi
critic
region
essenti
highli
conserv
poxviru
protein
data
indic
bind
fab
region
albeit
high
concentr
neutral
viru
infect
possibl
model
bind
compound
structur
develop
candid
antivir
drug
may
effici
neutral
viru
serum
compound
could
cross
cell
membran
might
possibl
neutral
infect
morphogenesi
prevent
infecti
viru
releas
dissemin
vero
cell
maintain
monolay
eagl
minim
essenti
medium
emem
supplement
contain
vv
fetal
calf
serum
hyclon
logan
ut
mm
hepe
uml
penicillin
streptomycin
vacv
strain
ihdj
western
reserv
wr
propag
vero
monolay
clarifi
crude
lysat
store
use
wr
purifi
sucros
gradient
centrifug
g
h
rotor
beckman
palo
alto
ca
wr
band
harvest
gradient
use
glass
pasteur
pipett
obtain
cultur
supernat
hybridoma
cell
purifi
mabtrap
antibodybind
column
amersham
bioscienc
accord
manufactur
protocol
gener
use
immunopur
f
prepar
kit
pierc
rockford
il
follow
manufactur
recommend
protocol
briefli
concentr
mgml
f
digest
buffer
consist
mm
sodium
acet
ph
concentr
mab
incub
overnight
immobil
pepsin
constant
agit
separ
undigest
mab
f
ab
perform
affin
pak
protein
bind
column
ensur
undigest
mab
remov
f
prepar
digest
mab
pass
column
second
time
recov
f
concentr
kda
molecular
weight
cutoff
mwco
concentr
millipor
bedford
mm
triscl
buffer
fragment
gener
use
immunopur
fab
prepar
kit
pierc
accord
recommend
protocol
purifi
incub
overnight
pb
ph
contain
immobil
papain
undigest
mab
separ
fab
fragment
use
protein
bind
column
fab
fragment
run
column
second
time
ensur
intact
adsorb
fab
prepar
fab
fragment
concentr
use
mwco
concentr
mm
triscl
buffer
vacvspecif
elisa
perform
essenti
describ
hooper
et
al
purifi
vacv
strain
wr
dilut
pb
ad
well
highbind
elisa
plate
corn
corn
ny
dri
overnight
mock
antigen
also
plate
mock
antigen
prepar
load
uninfect
cell
lysat
onto
sucros
gradient
harvest
portion
sucros
gradient
purifi
viru
remov
sampl
treat
uv
light
overnight
distanc
cm
standard
safeti
light
use
laminar
flow
hood
plate
block
h
pb
contain
vv
pbst
wv
dri
milk
serial
dilut
fragment
made
block
buffer
dilut
incub
bound
vacv
h
incub
plate
wash
four
time
pbst
incub
peroxidaseconjug
antimous
fabspecif
antibodi
sigma
st
loui
mo
min
plate
subsequ
wash
four
time
acid
abt
substrat
kpl
gaithersburg
md
ad
well
reaction
stop
ad
abt
stop
solut
wv
sodium
dodecylsulf
optic
densiti
od
nm
read
spectramax
elisa
plate
reader
molecular
devic
sunnyval
ca
dilut
seri
od
valu
mock
antigen
well
subtract
experiment
valu
sampl
run
duplic
elisa
perform
essenti
previous
describ
hooper
et
al
purifi
su
et
al
dilut
carbon
buffer
ph
plate
ng
well
plate
plate
incub
room
temperatur
overnight
presenc
absenc
uv
light
describ
remaind
assay
perform
describ
plaqu
reductionneutr
test
prnt
perform
describ
previous
hooper
et
al
vacv
strain
ihdj
incub
either
indic
concentr
h
total
volum
viru
mixtur
ad
confluent
monolay
cell
plate
plate
viru
adsorb
cell
h
rock
everi
min
adsorpt
mixtur
ml
methylcellulos
wv
water
eagl
basal
medium
earl
salt
ebm
ad
well
plate
incub
stain
crystal
violet
min
wash
water
indic
condit
antimous
fab
antibodi
sigma
incub
fragment
fragment
prebound
vacv
h
follow
incub
antifab
antibodi
h
experi
perform
duplic
determin
molecul
inhibit
postattach
event
vacv
entri
plaqueform
unit
pfu
vacv
adsorb
monolay
plate
plate
h
unbound
viru
remov
aspir
cell
wash
pb
adsorb
viru
next
incub
indic
concentr
fragment
h
incub
one
group
incub
antifab
antibodi
h
well
incub
equival
volum
pb
h
methylcellulos
ad
well
plate
incub
day
plate
stain
describ
prnt
sampl
test
duplic
plasmid
describ
elsewher
hooper
et
al
missens
mutat
chang
asp
posit
asn
introduc
perform
two
separ
pcr
step
first
reaction
use
primer
second
reaction
use
primer
underlin
codon
encod
mutat
pcr
reaction
amplifi
part
gene
two
pcr
reaction
consist
part
gene
contain
mutat
gel
purifi
final
pcr
reaction
perform
combin
pcr
fragment
primer
primer
amplifi
entir
code
region
also
introduc
nhei
bglii
site
product
result
pcr
product
digest
nhei
bglii
new
england
biolab
ipswich
clone
pwrgtpa
vector
mutat
form
verifi
dna
sequenc
cell
monolay
confluent
transient
transfect
empti
vector
use
roch
indianapoli
accord
manufactur
recommend
transfect
cell
incub
h
trypsin
wash
emem
cell
transfer
tube
cell
incub
appropri
antibodi
h
room
temperatur
continu
agit
incub
primari
antibodi
cell
pellet
centrifug
g
min
wash
twice
pb
cell
next
incub
antimous
alexa
invitrogen
carlsbad
ca
min
room
temperatur
incub
secondari
antibodi
cell
pellet
centrifug
g
min
wash
cell
resuspend
ml
fac
buffer
flow
cytometri
perform
facscalibur
flow
cytomet
becton
dickinson
san
jose
ca
data
collect
analyz
use
cell
quest
softwar
obtain
sequenc
variabl
region
rna
isol
hybridoma
use
trizol
accord
manufactur
instruct
invitrogen
carlsbad
ca
firststrand
dna
synthes
rna
use
superscript
iii
firststrand
kit
invitrogen
carlsbad
ca
product
use
templat
round
pcr
primer
use
pcr
light
chain
primer
use
heavi
chain
novagen
mous
igprim
set
emd
bioscienc
san
diego
ca
heavi
chain
primer
igprim
set
produc
pcr
product
follow
four
primer
design
base
result
ntermin
protein
sequenc
primer
primer
primer
primer
four
pcr
reaction
yield
product
final
sequenc
confirm
least
two
clone
four
pcr
product
two
plasmid
contain
variabl
region
heavi
light
chain
design
respect
vacv
protein
express
purifi
previous
describ
su
et
al
purifi
mix
molar
ratio
final
total
protein
concentr
mgml
crystal
complex
obtain
hang
drop
vapor
diffus
method
protein
solut
mix
reservoir
solut
best
crystal
obtain
streak
seed
small
crystal
use
reservoir
solut
triscl
ph
crystal
flashfrozen
data
collect
solut
contain
triscl
ph
glycerol
xray
data
collect
integr
scale
use
softwar
otwinowski
minor
model
variabl
constant
domain
fab
pdb
code
granata
et
al
model
pdb
code
su
et
al
use
search
model
determin
structur
molecular
replac
program
phaser
mccoy
et
al
use
singl
search
posit
four
copi
constant
domain
four
copi
variabl
domain
final
four
copi
iter
model
build
jone
et
al
base
electron
densiti
map
follow
refin
refmac
murshudov
et
al
cn
adam
et
al
improv
electron
densiti
assign
sidechain
rotam
variabl
region
fab
rebuilt
base
sequenc
obtain
noncrystallograph
symmetri
restraint
among
four
copi
complex
asymmetr
unit
use
refin
residu
termini
disord
structur
built
model
buri
surfac
area
calcul
perform
use
cn
lee
richard
shape
correl
statist
calcul
use
sc
lawrenc
colman
figur
gener
use
pymol
delano
coordin
complex
deposit
research
collaboratori
structur
bioinformat
protein
data
bank
rcsb
pdb
code
interact
f
fab
fragment
purifi
vacv
recombin
bind
purifi
vacv
serial
twofold
dilut
neg
control
antibodi
start
test
capac
bind
purifi
viru
vacvinfectedcel
lysat
elisa
antigenco
plate
treat
uv
light
grey
dash
line
incub
uv
symbol
repres
mean
standard
deviat
sd
duplic
sampl
b
bind
recombin
serial
twofold
dilut
neg
control
antibodi
start
test
capac
bind
recombin
elisa
purifi
ngwell
untreat
treat
uv
light
grey
dash
line
symbol
repres
mean
sd
duplic
sampl
xax
b
plot
log
scale
smallest
error
bar
b
hidden
beneath
symbol
seen
plaqu
reductionneutr
test
use
vacv
incub
purifi
h
virusantibodi
mixtur
untreat
viru
adsorb
confluent
monolay
cell
follow
addit
semisolid
overlay
methylcellulos
describ
method
plaqu
count
stain
crystal
violet
percent
neutral
plaqu
format
antibodi
addit
rel
untreat
viru
plot
versu
concentr
log
scale
b
vacv
incub
concentr
indic
h
one
sampl
incub
fab
incub
antifab
antibodi
h
sampl
incub
addit
h
absenc
antifab
antibodi
incub
viru
ad
cell
plaqu
format
analyz
describ
c
confluent
monolay
cell
chill
ice
incub
pfu
vacv
strain
ihdj
per
well
h
adsorpt
viru
remov
ad
well
indic
concentr
h
incub
antifab
antibodi
ad
well
sampl
anoth
h
plate
incub
plaqu
visual
describ
structur
bound
recogn
loop
connect
helic
strand
ribbon
diagram
show
bound
gray
color
secondari
structur
sheet
red
helic
blue
loop
green
disulfid
bond
shown
yellow
b
heavi
chain
provid
interact
orient
surfac
diagram
color
polypeptid
chain
heavi
chain
orang
light
chain
green
blue
calcul
total
buri
surfac
area
shape
complementar
statist
antibodi
chain
indic
interact
monoclon
antibodi
mutat
cell
transfect
black
line
grey
line
empti
pwrg
vector
solid
grey
cell
incub
dilut
control
antibodi
antimous
secondari
antibodi
conjug
alexa
fluorochrom
ad
cell
analyz
flow
cytometri
use
facscalibur
flow
cytomet
sampl
cell
count
b
hydrogen
bond
involv
bind
determin
crystal
structur
shown
blue
atom
critic
residu
shown
stick
carbon
atom
retain
color
loop
belong
loop
green
loop
blue
loop
purpl
loop
brown
structur
upper
panel
green
make
hydrogen
bond
side
chain
heavi
chain
gray
also
shown
hydrogen
bond
carbonyl
oxygen
blue
heavi
chain
gray
lower
panel
predict
bind
mutant
model
shown
hydrogen
bond
green
heavi
chain
would
analog
bond
made
new
hydrogen
bond
red
form
altern
rotam
fab
heavi
chain
maintain
hydrogen
bond
red
heavi
chain
structur
rotat
around
vertic
axi
rel
orient
fig
c
align
ectodomain
sequenc
vacv
variola
viru
monkeypox
viru
residu
shown
differ
vaccinia
viru
sequenc
residu
four
loop
shade
fig
loop
green
loop
blue
loop
purpl
loop
brown
residu
involv
van
der
waal
interact
mark
one
dot
residu
also
mediat
hydrogen
bond
mark
two
dot
sequenc
cystein
highlight
yellow
hydrogen
bond
list
atom
correspond
loop
hydrogen
bond
partner
heavi
chain
hc
correspond
complementaritydetermin
region
cdr
loop
distanc
virolog
author
manuscript
avail
pmc
novemb
